Responses
Clinical/translational cancer immunotherapy
Original research
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Compose a Response to This Article
Other responses
No responses have been published for this article.
